CIK 0001842952 · <br>Emerging growth company
Context Therapeutics Inc.
Sign in to watch- Ticker
- CNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863738787
- Phone
- 267-225-7416
- Business address
- 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA, PA, 19103
- Former names
- Context Therapeutics LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Other acquisition · Warrant (right to buy) | +52,680 | 0 | ||
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Conversion · Series A Preferred Stock | −210,722 | 0 | ||
| 2021-10-22 | Lehr Martin A. Chief Executive Officer | Conversion · Series Seed Preferred Stock | −586,476 | 0 | ||
| 2021-10-22 | Dick Evan G. SVP of R&D | Conversion | +26,587 | 87,139 | ||
| 2021-10-22 | Dick Evan G. SVP of R&D | Conversion · Series Seed Preferred Stock | −26,587 | 0 |
Page 5 of 5 · 85 trades